Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recruiting × Electroporation × Clear all

Phase

Phase NA 4 Phase 2/3 1 Phase 2 1 Phase 1 1

Status

Completed 4 Unknown 3 Terminated 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Gynecological Cancers 1

Interventions

pembrolizumab 207 Carboplatin 190 Specimen Handling 172 Cisplatin 169 Magnetic Resonance Spectroscopy 150 Radiotherapy 128 Bevacizumab 122 Gemcitabine 112 Cyclophosphamide 110 Drug Therapy 104 Capecitabine 101 Paclitaxel 97 venetoclax 96 Nivolumab 95 Oxaliplatin 87 Biopsy 87 durvalumab 75 tislelizumab 72 Rituximab 72 Etoposide 62 toripalimab 61 Radiosurgery 61 Fluorouracil 61 atezolizumab 60 Docetaxel 60 Pemetrexed 58 Dexamethasone 57 lenvatinib 54 Azacitidine 54 sintilimab 51

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04760327 2024-10-17

GynECT

Institute of Oncology Ljubljana

Phase 2 Recruiting

Gynecological Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡